1. Home
  2. DGX vs KEY Comparison

DGX vs KEY Comparison

Compare DGX & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
    SELLHOLDBUYas of a day ago
  • KEY
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • DGX 1967
  • KEY 1825
  • Country
  • DGX United States
  • KEY United States
  • Employees
  • DGX N/A
  • KEY N/A
  • Industry
  • DGX Medical Specialities
  • KEY Major Banks
  • Sector
  • DGX Health Care
  • KEY Finance
  • Exchange
  • DGX Nasdaq
  • KEY Nasdaq
  • Market Cap
  • DGX 19.2B
  • KEY 18.8B
  • IPO Year
  • DGX 1996
  • KEY N/A
  • Fundamental
  • Price
  • DGX $167.31
  • KEY $15.77
  • Analyst Decision
  • DGX Buy
  • KEY Buy
  • Analyst Count
  • DGX 13
  • KEY 20
  • Target Price
  • DGX $178.38
  • KEY $19.15
  • AVG Volume (30 Days)
  • DGX 1.2M
  • KEY 16.4M
  • Earning Date
  • DGX 04-22-2025
  • KEY 04-17-2025
  • Dividend Yield
  • DGX 1.91%
  • KEY 5.19%
  • EPS Growth
  • DGX 2.67
  • KEY N/A
  • EPS
  • DGX 7.69
  • KEY N/A
  • Revenue
  • DGX $9,872,000,000.00
  • KEY $4,239,000,000.00
  • Revenue This Year
  • DGX $10.28
  • KEY $75.54
  • Revenue Next Year
  • DGX $3.84
  • KEY $7.23
  • P/E Ratio
  • DGX $21.76
  • KEY N/A
  • Revenue Growth
  • DGX 6.70
  • KEY N/A
  • 52 Week Low
  • DGX $125.42
  • KEY $13.11
  • 52 Week High
  • DGX $178.87
  • KEY $20.04
  • Technical
  • Relative Strength Index (RSI)
  • DGX 47.83
  • KEY 40.75
  • Support Level
  • DGX $164.61
  • KEY $15.13
  • Resistance Level
  • DGX $168.14
  • KEY $16.86
  • Average True Range (ATR)
  • DGX 3.50
  • KEY 0.42
  • MACD
  • DGX -0.78
  • KEY 0.09
  • Stochastic Oscillator
  • DGX 36.28
  • KEY 45.23

Stock Price Comparison Chart: DGX vs KEY

DGX
KEY
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160180DGX VS KEY

About DGX Quest Diagnostics Incorporated

Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About KEY KeyCorp

With assets of over $180 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use